China released its 2026 national reimbursement drug list (NR
文 / 小金
2026-11-14 12:02:27
来源:亚金网
China released its 2026 national reimbursement drug list (NRDL) and a parallel commercial health insurance innovative drug list, adding 107 medicines to the NRDL, including a record 51 Category I new drugs covering oncology, rare diseases, chronic and psychiatric indications. The NRDL now totals 3,331 products (1,935 Western drugs; 1,396 traditional Chinese medicines) and takes effect Jan. 1, 2027. The commercial list added 12 drugs — including the world’s first solid‑tumor CAR‑T and China’s first hemophilia gene therapy — bringing that list to 28.
